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Abstract 
Twelve Enterobacteriaceae (n=10 E coli, n=1 K. pneumoniae and n=1 P. reflgen) res1stant to 
cefotax1me and/or ceftazidime were ISOlated from ten s1ck piglets 1n the same pig farm in October 
2006 All the stra1ns were multi-drug res1stant and confirmed as ESBLs producers by synergy tests 
PCR and sequencing were carried out to detect the bla genes. The E colt isolates and P.rettgen 
harboured the blacrx-M·l· the K. pneumontae isolate were positive for SHV bla gene (99% of 
omology with blasHV-28) . All the ISolates but P reflgen carried a TEM-1 13-lactamase as well . 
Th1s study represents the first report of Enterobactenaceae ESBLs-producmg other than E. coli 
and Salmonella in veterinary microbiology. 
Introduction 
The spread of res1stance to Extended-Spectrum Cephalosponns (ESC) 1s an 1ssue of grow1ng 
concern in human medicine (Paterson D. L. , 2006). This class of 13-lactams as well as 
nuoroqUtnolones are antimicrobials w1dely used in the therapy of complicated 1nfect1ons mdeed 
Although ESC are not drugs frequently used in veterinary practice, the number of reports recording 
E colt and Salmonella entenca ESC-res1stant Isolates from ammals has recently increased m 
Europe 
E coli ESBLs-producing have been isolated from poultry in Spain and Italy (Brinas et al 
2003,2005, Ch1aretto et al 2006), from cattle m UK (Uebana et al. 2006,) and from compamon 
animals in Italy and Portugal (Carattoll et al. 2005, Costa et al. 2004, Ch1aretto et al. 2006). On the 
other hand, only few recent studies reported the recovery of E. coli with ESBL phenotype from p1gs 
(Meumer et al 2006 Blanc et al. 2006). 
The class A ESBLs belong mainly to TEM, SHV and CTX-M fam1ly The CTX-M enzymes, 
described m late '80 for the first lime, have become the most prevalent ESBLs worldwide in 
humans (Cant6n and Coque, 2006). The recovery of E coli and Salmonella carrymg blacrx-M 
genes has been also repored from d1fferent ammal sources (poultry, cattle, pig , pet) in Europe 
(Weill et al 2004, L1ebana et al 2006, Meunier et al 2006, R1afio I • et al . 2006 Carattoli et al 
2005). 
The a1m of th1s study was to characterize at a molecular level ESBLs-producing enterobacteria 
isolated from ten piglets with septicaemia at the same pig farm. Th1s study 1s the first report of 
Enterobactenaceae ESBLs-producmg other than E colt and Salmonella in veterinary m1crob1ology 
Material and Methods 
Bactenal Strams 
Twelve ESBLs-producmg strains (n=1 0 E colt, n=1 K pneumontae and n=1 P rettgen) were 
Isolated from different organs of ten s1ck p1gs (ranging from 30 to 80 days old) after post-mortem 
exammallon. m October 2006 The ISOlates were identified biochemically by routine laboratory 
procedure and Ap120E system (Biomerieux) 
Susceptibility tests 
The antim1crob1al suscephb1hty was evaluated by d1sk diffusion w1th 16 d1fferent antimicrobial drugs 
(Becton 01c mson Microbiology Systems Cockeysville MD USA) on Mueller-H1nton (MH) agar 
according to the recommendations of the CLSI (formely NCCLS) The follow1ng antimicrobials were 
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tested : colistin (CL 10 ~g) , tnmethoprim-sulfamethoxazole (SXT 23, 75+ 1,25 ~g) , kanamycin (KAN 
30 ~g), gentamicin (GEN 10 ~g) , cefotax1me (CTX 30 ~g), amoxicillin-clavulanic ac1d (AMC 30 ~g), 
nalidixic acid (NAL 30 ~g) , tetracycline (TET 30 ~g), ampicillin (AMP 10 ~g) , streptomycin (STR 10 
~g) , chloramphenicol (CHL 30 ~g) , spectinomycin (SPT 100 ~g) , enrofloxacm (ENO 5 ~g) , 
sulfisoxazole (G 25 mg), ammos1dm (AN 60 ~g), apramycm (APRA 15 ~g) . The strams were also 
tested aga1nst three extra ~-lactams ceft1ofur (30 ~g) , cefoxitm (FOX 30 ~g) , 1m1penem (IMP 30 
~g)) The ESBL phenotype was assayed according to CLSI tests usmg ceftaz1dime and cefotax1me 
(30 ~g) and the same cephalosponns plus clavulanic ac1d (10 ~g) . The enhancement of the 
oxymmo-~-lactams mhib1tion zone (2: 5 mm) caused by clavulanate revealed the ESBL-producing 
strams E. coli A TCC25922 and K. pneumoniae ATCC 700603 were used as quality control strains 
for the ESBL phenotype screening tests. 
Genetic characterization of bla genes. 
Total DNA was extracted w1th lnstaGene matrix kit (Bio-Rad) in accordance with the 
manufacturer's recommendation . The detection of b/aTEM, b/aSHV, b/aCTX-M genes was earned 
out by PCR assays The primers used were either adapted from those previously published 
(l1ebana et al 2004 , We111 et al. 2004) or des1gned by usmg computer analys1s of ava1lable ~­
lactamase sequences (GenBank) (Table 2). 
Table 2 Primers and PCR conditions used in PCR analys1s 
---PCR Primer Sequence (5'-3') T c·c> PCR Reference target products 
b/8TEM TEM-F TCGTGTCGCCCTTATTCCCTTTTT 60 425 pb L1ebana 2004 
TEM-R GCGGTTAGCTCCTTCGGTCCTC 
TEM-8-F AGTCACAGAAAAGCATCTT 52 576 pb This study' 
TEM-8-R GAGTAAACTTGGTCTGACAG 
blasHV SHV-F CGGCCCCGCAGGATTGACT 60 409/849 pb L1ebana 2004 
SHV-Fmod'' GATGTATTGTGGTTATGCGTT 
SHV-R TCCCGGCGATTTGCTGATTTC 
b/acT><-M CTX M-F C(AIG )ATGTGCAG(CIT)ACCAGT AA 53 540 pb We1112004 
CTX-M-R CGC(AIG)AT ATC(AIG )TTGGTGGTG 
blac1 M CTX-M-F-1 ATGGTTAAAAAATCACTGC 53 886 pb Th1s study-·· 
CTX M-R 1 CGTTTCCGCTATTACAA Group1 
'primers TEM 8 F pOSition 315-333, TEM-8-R pos1t1on 862-881";' EM8L acceSSIOn number AY529705 
''primers SHV-Fmod pos1tion 185-205, EM8L access1on number AF124984 
'''pnmer CTX M gruppo1 , CTX M-F pos1t1on 63-81 , CT -M-R posit1on 871 -887, EM8L accession number 
X92506 
Sequencmq 
The purified PCR fragments were sequenced on both strands with the "BigDye terminator v3 1 
cycle sequencing" k1t (Applied Blosystems) usmg the same set of pnmers as for the PCRs (Table 
1) Sequence analys1s was performed on an 31 00-Avant Genetic Analyzer (Applied B1osystems) 
and analysed usmg the software SeqScape v2. 1 1 The obtained nucleotide sequences and the 
denved amino acid sequences were compared w1th those previously described from the GeneBank 
database www ncbl nlm nih gov and www Iahey org/studies/webt html , respectively 
Results 
Ten E. coli, one strain of K pneumomae and one stram of P rettgeri were 1dent1fied by b1ochem1cal 
te ts All the strains showed a multi-drug resistant phenotype (summanzed m table 1) and were 
confirmed s ESBLs producers by synergy tests All the E. coli strains and the P rettgeri 1solate 
carried CTX M enzyme classlfled s CTX-M I by DNA sequenc1ng 
Tho K pneumoniae isol te was poslllve to bla H gene, the sequence analysis of the ampllcon 
rave I d n omology of 99 % with the blasH 8 gene All the ISolates but the stram of P rettgen 
possessed the ~ Ia t mase TEM 1 The results of genetic ch racterizatton are shown in table 1 
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Discussion 
The CTX-M ~ -lactamases have become the most widely spread ESBLs worldwide (Canton and 
Coque, 2006). In this study, we found multi-drug resistant strains (E. coli and P. rettgeri) positive 
for the CTX-M-1 ~ -lactamase. Among the CTX-M enzymes, CTX-M group1 are recognized mainly 
in Europe. In particular, the CTX-M-1 ~-lactamase is the most prevalent variant reported in human 
E. coli and has been already reported in animals in Italy (Mugnaioli et al. 2006, Carattoli et al. 
2005). Furthermore, we found that in the same animal a strain of Klebsiella pneumoniae SHV 
positive and a strain of E. coli CTX-M -1 producing coexisted. This study represents the first report 
of Enterobacteriaceae ESBLs-producing other than E. coli and Salmonella in veterinary 
microbiology 
The strains were isolated from piglets coming from different areas in the same pig farm and we 
reported also the isolation of two different species (E. coli and P. rettgeri) carrying CTX-M-1 from 
the same animal. It is worth noting that the dissemination of CTX-M genes can follow different 
ways (Canton and Coque, 2006). In the farm under study, this could be due to the presence of a 
specific clone and/or mobile genetic elements. Further molecular investigations and monitoring will 
be needed to ascertain the mechanism/s of CTX-M-1 positive E. coli spreading and check the 
efficacy of the control actions adopted. 
Conclusion 
The antibiotic resistance is a issue of growing concern in human and veterinary medicine. In 
particular, antimicrobials such as cephalosporins and fluoroquinolones represent major 
therapeutical options in complicated human infections. The recovery of ESBLs- producing 
Enterobacteriaecae animal-associated demands surveillance actions focused on cephalosporins 
resistance to understand the interplay among animals and humans related to the diffusion of 
cephalosporin resistance genetic determinants. On the other hand, the prudent use of 
antimicrobials remains the first action to preserve their effectiveness. 
Table 1: ESBLs- producin9 strains isolated from sick f2ifJiets {Dicember 2006~ 
Strain Species Resistance ~-lactamases 
_ .. , ___ 
3593 E. coli SXT -KAN-GM-CTX-AMC-TET -AMP-STR-CHL- CTX-M-1 , TEM-1 
SPT-G-AN-EFT 
3595 E. coli SXT -KAN-GM-CTX-AMC-TET -AMP-STR-G-AN- CTX-M-1 , TEM-1 
APRA-EFT 
3616 E. coli SXT -KAN-GM-CTX-AMC-TET -AMP-STR-G-AN- CTX-M-1, TEM-1 
EFT 
3620 E. coli SXT -KAN-GM-CTX-AMC-TET -AMP-STR-CHL- CTX-M-1 , TEM-1 
SPT -G-AN-EFT 
3622 E. coli SXT -KAN-CTX-AMC-NAL-TET -AMP-STR-CHL- CTX-M-1 , TEM-1 
G-AN-EFT 
3623 E. coli SXT -KAN-CTX-AMC-CTX-NAL-TET -AMP-STR- CTX-M-1 , TEM-1 
CHL-G-AN-EFT 
3623 K. pneumoniae SXT -KAN-CTX-AMC-NAL-TET -AMP-CHL-ENO- blasHv. TEM-1 
G-EFT 
3696 E. coli SXT -KAN-GM-CTX-AMC-NAL-TET -AMP-STR- CTX-M-1, TEM-1 
G-AN-EFT 
3857 E. coli SXT -KAN-GM-CTX-AMC-NAL-TET -AMP-SPT- CTX-M-1 , TEM-1 
CHL-ENO-G-AN-EFT 
3858 E. coli SXT -KAN-GM-CTX-AMC-NAL-TET -AMP-SPT- CTX-M-1, TEM-1 
CHL-ENO-G-AN-APRA 
3859 E. coli SXT -KAN-GM-CTX-AMC-TET -AMP-STR-C- CTX-M-1 , TEM-1 
SPT -G-AN-EFT 
3859 P. rettgeri CL-SXT -KAN-CTX-AMC-TET -AMP-STR-C- CTX-M-1 
SPT-G-AN-APRA-EFT 
CL: colistin, SXT: trimethoprim-sulfamethoxazole, KAN: kanamycin, GEN: gentamicin, 
cefotaxime, AMC: amoxicillin-clavulanic acid, NAL nalidixic acid, TET tetracycline, AMP ampicillin, 
~ 
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STR streptomycin, CHL. chloramphemcol, SPT spectmomycm, ENO enrofloxacin, G: sulfisoxazole, 
AN ammos1d1n, APRA apramycin, EFT ceftiofur. 
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